Tumour model

SK-OV-3

Clear cells carinoma
XenograftIn vitro

SK-OV-3 cells

Human SK-OV-3 cells were isolated from the ovary of patient with ovarian adenocarcinoma.

Tumour growth in vivo

The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of SCID/CB17 mice. The resulting tumours were monitored by measuring two diameters with calipers, and extrapolating the volume to a sphere.
The mice bearing SK-OV-3 tumours can be treated by intra-peritoneal, intra-venous, intra-tumoral or subcutaneous injection of the compounds. Per os administration is also possible.

Figure 1: (View PDF)
Tumour growth curve of the SK-OV-3 cells as subcutaneous tumors Mean ± SEM (n=4; take rate 100%)

Download PDF

Model characteristics

Organism
Human
Tissue of origin
Ovary
Pathology
Clear cells carinoma
Model type
In vitro, Xenograft
Availability
Off the shelf (time of expansion)

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Human
Ovary
XenograftIn vitro
Mouse
Ovary
Teratoma
SyngeneicIn vitro

KGN

Human
Ovary
Ovarian granulosa cell tumor
XenograftIn vitro
Human
Ovary
Endometrioid carcinoma
XenograftIn vitro
Human
Ovary
Primary Malignant Adenocarcinoma; Grade 3, stage IIIC
XenograftIn vitro
Human
Ovary
Malignant Papillary Serous Adenocarcinoma
XenograftIn vitro